Connection

David Mahvi to Follow-Up Studies

Back to Details
This is a "connection" page, showing publications David Mahvi has written about Follow-Up Studies.
David Mahvi
Connection Strength
0.067
Follow-Up Studies
  1. Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma. Cancer Immunol Immunother. 2018 Oct; 67(10):1647-1658.
    View in: PubMed
    Score: 0.024
  2. Impact of selection bias on the utilization of adjuvant therapy for pancreas adenocarcinoma. Ann Surg Oncol. 2010 Feb; 17(2):371-6.
    View in: PubMed
    Score: 0.013
  3. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence. Ann Surg. 2008 Aug; 248(2):273-9.
    View in: PubMed
    Score: 0.012
  4. Inguinal hernias, endometriosis, and other adverse outcomes in rhesus monkeys following lead exposure. Neurotoxicol Teratol. 2003 Sep-Oct; 25(5):561-70.
    View in: PubMed
    Score: 0.008
  5. Mucinous ductal ectasia in an octogenarian: successful treatment with the Whipple procedure. Am J Gastroenterol. 1996 Feb; 91(2):388-90.
    View in: PubMed
    Score: 0.005
  6. Instrumented laparoscopic spinal fusion. Preliminary Results. Spine (Phila Pa 1976). 1995 Sep 15; 20(18):2029-34;discussion 2034-5.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.